| abstract |
The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where Ar1, A Hy, R1, m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses of, and processes of making the compounds, as well as methods of medical treatment of mGluR5-mediated disorders. |